Type of Care:
Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Outpatient Partial hospitalization/day treatment
Facility Type:
Outpatient mental health facility
Pharmacotherapies:
Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Prochlorperazine Thiothixene Thioridazine Trifluoperazine Aripiprazole Brexpiprazole Cariprazine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Cognitive behavioral therapy Cognitive remediation therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale
Facility Operation (e.g., Private, Public):
Private for-profit organization
Payment Assistance Available:
Sliding fee scale (fee is based on income and other factors)
Special Programs/Groups Offered:
Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
TB screening Metabolic syndrome monitoring Laboratory testing
Recovery Support Services:
Mentoring/peer support
Education and Counseling Services:
Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy :
Smoking permitted in designated area
Age Groups Accepted:
Young Adults Adults Seniors
Facility Vaping Policy:
Vaping permitted without restriction
Ancillary Services:
Chronic disease/illness management Diet and exercise counseling Illness management and recovery Psychosocial rehabilitation services Vocational rehabilitation services Case management service Integrated primary care services Suicide prevention services Education services